Cyclodextrins in drug delivery systems

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 4, 2010, Pages 289-301

  Otero Espinar, F J ^a   Torres Labandeira, J J ^a   Alvarez Lorenzo, C ^a   Blanco Mendez J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cyclodextrin; Drug cyclodextrin conjugates; Hydrogels; Liposomes; Multiparticulate systems; Nanoparticles; Poly(pseudo)rotaxanes; Tablets

Indexed keywords

CELECOXIB; CYCLODEXTRIN; DEXAMETHASONE; GLIBENCLAMIDE; IBUPROFEN; INDOMETACIN; LIPOSOME; METFORMIN; MICROCRYSTALLINE CELLULOSE; NANOPARTICLE; NAPROXEN; OMEPRAZOLE; PARACETAMOL; PIROXICAM; PRASTERONE; PROPRANOLOL; QUERCETIN; RECOMBINANT GROWTH HORMONE; RETINOIC ACID; RETINOL; ROFECOXIB; SERTACONAZOLE; SOLUBILIZER; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

COLLOID; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG PELLET; HUMAN; HYDROGEL; MACROMOLECULE; MICROPARTICLE ENZYME IMMUNOASSAY; PHYSICAL CHEMISTRY; REVIEW; SOLID; TABLET FORMULATION;

EID: 78149392568     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50046-7     Document Type: Review

References (204)

1. Dutta R.C. - Drug carriers in pharmaceutical design: promises and progress. - Current Pharmaceutical Design, 13, 761-769, 2007. (Pubitemid 46510751)
2. Loftsson T., Duchêne D. - Cyclodextrins and their pharmaceutical applications. - Int. J. Pharm., 329, 1-11, 2007.
3. Bender M.L., Komiyama M. - Cyclodextrin Chemistry. - Springer-Verlag, Berlin-New York, 1978.
4. Duchêne D. (Ed.) - New Trends in Cyclodextrins and Derivatives. - Editions de Santé, Paris, 1991.
5. Duchêne D. (Ed.) - Cyclodextrins and Their Industrial Uses. - Editions de Santé, Paris, 1987.
6. Brewster M.E., Loftsson T. - Cyclodextrins as pharmaceutical solubilizers. - Adv. Drug. Del. Rev., 59, 645-666, 2007.
7. Dodziuk H. (Ed.) - Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications. - Wiley-VCH Verlag GmbH & Co., Weinheim, 2006.
8. Uekama K., Hirayama F., Irie T. - Cyclodextrin drug carrier systems. - Chem. Rev., 98, 2045-2076, 1998.
9. Challa R., Ahuja A., Ali J., Khar R.K. - Cyclodextrins in drug delivery: an updated review. - AAPS PharmSciTech, 6, Article 43, 2005. (Pubitemid 41631739)
10. Loftsson T., Brewster M.E., Masson M. - Role of cyclodextrins in improving oral drug delivery. - Am. J. Drug Del., 2, 261-275, 2004.
11. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. - Atheoretical basis for a biopharmaceutic drug classification - the correlation of in vitro drug product dissolution and in vivo bioavailability. - Pharm. Res., 12, 413-420, 1995.
12. Gupta E., Barends D.M., Yamashita E., Lentz K.A., Harmsze A.M., Shah V.P., Dressman J.B., Upper R.A. - Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. - Eur. J. Pharm. Sci., 29, 315-324, 2006.
13. Irie T., Uekama K. - Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation. - J. Pharm. Sci., 86, 147-162, 1997.
14. Frijlink H.W., Eissens A.C., Schoonen A.J.M., Lerk C.F. - The effects of cyclodextrins on drug absorption. 2. In vivo observations. - Int. J. Pharm., 64, 195-205, 1990.
15. Otero Espinar F.J., Anguiano Igea S., Blanco Mendez J., Vila Jato J.L. - Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrin. - Int. J. Pharm., 70, 35-41, 1991.
16. Piel G., Moutard S., Uhoda E., Pilard F., Pièrard G.E., Perly B., Delattre L., Evrard B. - Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. - Eur. J. Pharm. Biopharm., 57, 479-482, 2004.
17. Ahuja M., Dhake A.S., Sharma S.K., Majumdar D.K. - Topical ocular delivery of NSAIDs. - AAPS J., 10, 229-241, 2008.
18. Uekama K. - Design and evaluation of cyclodextrin-based drug formulation. - Chem. Pharm. Bull., 52, 900-915, 2004.
19. Wei H.L., Wang L.C., Zhang A.Y., Zhu K.Q., Feng Z.G. - Preparation and applications of injectable hydrogels. - Prog. Chem., 16, 1008-1016, 2004.
20. Harada A., Hashidzume A., Yamaguchi H., Takashima Y. - Polymeric rotaxanes. - Chem. Rev., 109, 5974-6023, 2009.
21. Li J., Loh X.J. - Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. - Adv. Drug. Del. Rev., 60, 1000-1017, 2008.
22. Udo K., Hokonohara K., Motoyama K., Arima H., Hirayama F., Uekama K. - 5-Fluorouracil acetic acid/β-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media. - Int. J. Pharm., 388, 95-100, 2010.
23. Banerjee S.S., Chen D.H. - Cyclodextrin-conjugated nanocarrier for magnetically guided delivery of hydrophobic drugs. - J. Nanopart. Res., 1-8, 2008.
24. Miller L.A., Carrier R.L., Ahmed I. - Practical considerations in development of solid dosage forms that contain cyclodextrin. - J. Pharm. Sci., 96, 1691-1707, 2007.
25. Maggi L., Conte U., Bettinetti G.P. - Technological properties of crystalline and amorphous β-cyclodextrin hydrates. - Int. J. Pharm., 172, 211-217, 1998.
26. Castro-Hermida J.A., Pors I., Otero-Espinar F., Luzardo-Alvarez A., Ares-Mazas E., Chartier C. - Efficacy of β-cyclodextrin against experimental cryptosporidiosis in neonatal goats. - Vet. Parasitol., 120, 35-41, 2004.
27. st International Symposium on Controlled Release of Bioactive Materials, Nice, 1994, CRS.5680728-729
28. Shangraw R.F., Pande G.S., Gala P. - Characterization of the tableting properties of β-cyclodextrin and the effects of processing variables on inclusion complex formation, compactibility and dissolution. - Drug Dev. Ind. Pharm., 18, 1831-1851, 1992.
29. Pande G.S., Shangraw R.F. - Characterization of β-cyclodextrin for direct compression tableting. - Int. J. Pharm., 101, 71-80, 1994.
30. Pande G.S., Shangraw R.F. - Characterization of β-cyclodextrin for direct compression tableting. 2. The role of moisture in the compactibility of β-cyclodextrin. - Int. J. Pharm., 124, 231-239, 1995.
31. Saleh S.I. - β-cyclodextrin as a direct compression excipient compared to conventional ones. - J. Pharm. Belg., 48, 7, 1993.
32. Shah P., Jambhekar S. - Coprocessing of β-cyclodextrin with alpha lactose monohydrate and its evaluation as a novel directly compressible filler. - AAPS J., 3, S1, 2001.
33. Tsai T.M., Wu J.S., Ho H.O., Sheu M.T. - Modification of physical characteristics of microcrystalline cellulose by codrying with beta-cyclodextrins. - J. Pharm. Sci., 87, 117-122, 1998.
34. Anguiano-Igea S., Otero Espinar F.J., Vila-Jato J.L., Blanco-Mendez J. - Evaluation of the sealed heating method for the obtention of a clofibrate/β-cyclodextrin inclusion complex. - STP Pharma Sci., 2, 325-331, 1992.
35. Suihko E., Korhonen O., Jarvinen T., Ketolainen J., Jahro P., Laine E., Paronen P. - Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin. - Int. J. Pharm., 215, 137-145, 2001.
36. Jarvinen T., Jarvinen K., Schwarting N., Stella V.J. - Beta-cyclodextrin derivatives, SBE4-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs. - J. Pharm. Sci., 84, 295-299, 1995.
37. Hirayama F., Uekama K. - Cyclodextrin-based controlled drug release system. - Adv. Drug. Del. Rev., 36, 125-141, 1999.
38. Horikawa T., Hirayama F., Uekama K. - In vivo and in vitro correlation for delayed-release behavior of a molsidomine o-carboxymethyl-o-ethyl-beta- cyclodextrin complex in gastric acidity-controlled dogs. - J. Pharm. Pharmacol., 47, 124-127, 1995.
39. Ikeda Y., Kimura K., Hirayama F., Arima H., Uekama K. - Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives. - J. Control. Rel., 66, 271-280, 2000.
40. Zugasti M.E., Zornoza A., Goni M.D., Isasi J.R., Velaz I., Martin C., Sanchez M., Martinez-Oharriz M.C. - Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. - Drug Dev. Ind. Pharm., 35, 1264-1270, 2009.
41. Gazzaniga A., Sangalli M.E., Bruni G., Zema L., Vecchio C., Giordano F. - The use of beta-cyclodextrin as a pelletization agent in the extrusion/spheronization process. - Drug Dev. Ind. Pharm., 24, 869-873, 1998.
42. Villar-Lopez M.E., Nieto-Reyes L., Anguiano-lgea S., Otero-Espinar E.J., Blanco-Mendez J. - Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. - Int. J. Pharm., 179, 229-235, 1999.
43. Villar-López M.E., Otero-Espinar F.J., Blanco-Méndez J.- Caracterización de membranas de Surelease/Pectina como posible recubrimiento de formas de liberación colónica. - IV Congreso AEDFG, Santiago de Compostela, 1999.
44. rd World Meeting APV/APGi, Berlin, 2000, 5732.
45. Debunne A., Vervaet C., Remon J.P. - Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs. - Eur. J. Pharm. Biopharm., 54, 343-348, 2002.
46. Sotthivirat S., Haslam J.L., Stella V.J. - Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutyl ether-beta-cyclodextrin, (SBE)(7M)-β-CD, as a solubilizing and osmotic agent. - J. Pharm. Sci., 96, 2364-2374, 2007.
47. Sotthivirat S., Haslam J.L., Lee P.I., Rao V.M., Stella V.J. - Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-β-cyclodextrin as both a solubilizing and osmotic agent. - J. Pharm. Sci., 98, 1992-2000, 2009.
48. Bon P., Joudieh S., Lahiani-Skiba M., Bounoure F., Dechelotte P., Skiba M. - Release of a poorly soluble drug from cross-linked β-cyclodextrin- based polymer pellets prepared via extrusion/spheronisation. - Letters in Drug Design & Discovery, 5, 462-470, 2008.
49. Zema L., Palugan L., Maroni A., Foppoli A., Sangalli M.E., Gazzaniga A. - The use of β-cyclodextrin in the manufacturing of disintegrating pellets with improved dissolution performances. - AAPS PharmSciTech, 9, 708-717, 2008.
50. Zhang X.W., Wu D.N., Lai J., Lu Y., Yin Z.N., Wu W. - Piroxicam/2-hydroxypropyl-β-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. - J. Pharm. Sci., 98, 665-675, 2009.
51. Bochot A., Trichard L., Le Bas G., Alphandary H., Grossiord J.L., Duchene D., Fattal E. - β-cyclodextrin/oil beads: an innovative self-assembling system. - Int. J. Pharm., 339, 121-129, 2007.
52. Trichard L., Fattal E., Le Bas G., Duchêne D., Grossiord J.L., Bochot A. - Formulation and characterisation of beads prepared from natural cyclodextrins and vegetable, mineral or synthetic oils. - Int. J. Pharm., 354, 88-94, 2008.
53. Trichard L., Fattal E., Besnard M., Bochot A. - β-cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs. - J. Control. Rel., 122, 47-53, 2007.
54. Trichard L., Delgado-Charro M.B., Guy R.H., Fattal E., Bochot A. - Novel beads made of β-cyclodextrin and oil for topical delivery of a lipophilic drug. - Pharm. Res., 25, 435-440, 2008.
55. Yadav B., Yadav A.V. - Effect of different stabilizers and polymers on spherical agglomerates of gresiofulvine by emulsion solvent diffusion (ESD) system. - Int. J. Pharm. Tech. Res., 1, 9, 2009.
56. Anguiano-Igea S. - Incorporation of liquid drugs to solid dispersions and cyclodextrin inclusion complex. Characterization and studies with clofibrate in farmacy and pharmaceutical technology. - PhD Thesis, University of Santiago de Compostela, Santiago de Compostela, 1992.
57. Maestrelli F., Zerrouk N., Cirri M., Mennini N., Mura P. - Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. - Eur. J. Pharm. Sci., 34, 1-11, 2008.
58. Blanco J., Vila-Jato J.L., Otero F., Anguiano S. - Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins. - Drug Dev. Ind. Pharm., 17, 943-957, 1991.
59. Otero-Espinar F.J., Anguiano-Igea S., Garcia-Gonzalez N., Vila-Jato J.L., Blanco-Mendez J. - Interaction of naproxen with β-cyclodextrin in solution and in the solid state. - Int. J. Pharm., 79, 149-157, 1992.
60. Hodi K., Tasic L., Kata M., Selmeczi B., Jovanovic M., Djuric Z. - Morphological-study of products containing β-cyclodextrin. - Starch-Starke, 43, 186-190, 1991.
61. Esclusa Diaz M.T., Torres Labandeira J.J., Kata M., Vila Jato J.L. - Inclusion complexation of glibenclamide with hydroxypropyl-cyclodextrin in solution and in solid-state. - Eur. J. Pharm. Sci., 1, 291-296, 1994.
62. Moyano J.R., Arias Blanco M.J., Gines J.M., Giordano F. - Study of the complexation behaviour of gliclazide with partially methylated β-cyclodextrin in solution and solid state. - Int. J. Pharm., 157, 239-243, 1997.
63. Baboota S., Dhaliwal M., Kohli K., Ali J. - Molecular inclusion of rofecoxib with cyclodextrin: pharmacological properties in laboratory animals. - Pharmazie, 59, 233-234, 2004. (Pubitemid 38391433)
64. Sinha V.R., Anitha R., Ghosh S., Nanda A., Kumria R. - Complexation of celecoxib with β-cyclodextrin: characterization of the interaction in solution and in solid state. - J. Pharm. Sci., 94, 676-687, 2005.
65. Corti G., Capasso G., Maestrelli F., Cirri M., Mura P. - Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin. - J. Pharm. Biomed., 45, 480-486, 2007.
66. Figueiras A., Carvalho R.A., Ribeiro L., Torres-Labandeira J.J., Veiga F.J.B. - Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. - Eur. J. Pharm. Biopharm., 67, 531-539, 2007.
67. Ferrari F, Sorrenti M., Rossi S., Catenacci L., Sandri G., Bonferoni M.C., Caramella C., Bettinetti G. - Vancomycin-triacetyl cyclodextrin interaction products for prolonged drug delivery. - Pharm. Dev.Technol., 13, 65-73, 2008.
68. Jalalipour M., Najafabadi A.R., Gilani K., Esmaily H., Tajerzadeh H. - Effect of dimethyl-β-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats. - J. Pharm. Sci., 97, 5176-5185, 2008.
69. Salustio P.J., Feio G., Figueirinhas J.L., Pinto J.F., Marques H.M.C. - The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity. - Eur. J. Pharm. Biopharm., 71, 377-386, 2009.
70. Zheng Y., Chow A.H.L. - Production and characterization of a spray-dried hydroxypropyl-β-cyclodextrin/quercetin complex. - Drug Dev. Ind. Pharm., 35, 727-734, 2009.
71. Torres Labandeira J.J., Echezarreta Lopez M., Santana Penin L., Vila Jato J.L. - Glibornuride-β-cyclodextrin inclusion complexes, Preparation, structural characterization and in vitro dissolution behavior. - Eur. J. Pharm. Biopharm., 39, 255-259, 1993.
72. Mammucari R., Dehghani F., Foster N.R. - Dense gas processing of micron-sized drug formulations incorporating hydroxypropylated and methylated beta-cyclodextrin. - Pharm. Res., 23, 429-437, 2006.
73. Reverchon E., Antonacci A. - Cyclodextrins micrometric powders obtained by supercritical fluid processing.- Biotechnol. Bioeng., 94, 753-761, 2006. (Pubitemid 44014205)
74. De Marco I., Reverchon E. - Supercritical antisolvent micronization of cyclodextrins. - Powder Technol., 183, 239-246, 2008. (Pubitemid 351384803)
75. Sahoo N.G., Abbas A., Li C.M. - Micro/nanoparticle design and fabrication for pharmaceutical drug preparation and delivery applications. - Curr. Drug Ther., 3, 78-97, 2008.
76. Loftsson T., Kristmundsdottir T. - Microcapsules containing water-soluble cyclodextrin inclusion complexes of water-insoluble drugs. - ACS Sym. Ser., 520, 168-189, 1993.
77. Bibby D.C., Davies N.M., Tucker I.G. - Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. - Int. J. Pharm., 197, 1-11, 2000.
78. Kwona M.J., Baea J.H., Kima J.J., Nab K., Lee E.S. - Long acting porous microparticle for pulmonary protein delivery. - Int. J. Pharm., 333, 5-9, 2007.
79. Morlock M., Koll H., Winter G., Kissel T. - Microencapsulation of rh-erythropoietin, using biodegradable poly(QL-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. - Eur. J. Pharm. Biopharm., 43, 29-36, 1997.
80. Kang F., Singh J. - Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis. - Int. J. Pharm., 260, 149-56, 2003.
81. Castellanos I.J., Flores G., Griebenow K. - Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. - J. Pharm. Sci., 95, 849-58, 2006.
82. Lee E.S., Kwon M.J., Lee H., Kim J.J. - Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous s/w/o/w method. - Int. J. Pharm., 331, 27-37, 2007.
83. Song C.X., Labhasetwar V., Levy R.J. - Controlled release of U-86983 from double-layer biodegradable matrices: effect of additives on release mechanism and kinetics. - J. Control. Rel., 45, 177-192, 1997.
84. Koushik K., Dhanda D.S., Cheruvu N.P.S., Kompella U.B. - Pulmonary delivery of deslorelin: large-porous PLGA particles and HPβCD complexes. - Pharm. Res., 21, 1119-1126, 2004.
85. Lopedota A., Trapani A., Cutrignelli A., Laquintana V., Denora N., Franco M., Trapani G., Liso G. - Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione. - J. Incl. Phenom. Macro., 57, 425-432, 2007.
86. Kwak H.H., Shim W.S., Choi M.K., Son M.K., Kim Y.J., Yang H.C., Kim T.H., Lee G.I., Kim B.M., Kang S.H., Shim C.K. - Development of a sustained-release recombinant human growth hormone formulation. - J. Control. Rel., 137, 160-5, 2009.
87. De Rosa G., Larobina D., La Rotonda M.I., Musto P., Quaglia F., Ungaro F. - How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system. - J. Control. Rel., 102, 71-83, 2005.
88. Malaekeh-Nikouei B., Tabassi S.A.S., Jaafari M.R., Davies N.M. - The effect of complexation on characteristics and drug release from PLGA microspheres loaded by cyclosporine-cyclodextrin complex. - J. Drug Deliv. Sci. Tech., 16, 345-350, 2006.
89. Ungaro F., De Rosa G., Miro A., Quaglia F., La Rotonda M.I. - Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. - Eur. J. Pharm. Sci., 28, 423-432, 2006.
90. Ungaro F., Bianca R.D.D.V., Giovino C., Miro A., Sorrentino R., Quaglia F., La Rotonda M.I. - Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. - J. Control. Rel., 135, 25-34, 2009.
91. Filipovic Grcic J., Becirevic Lacan M., Skalko N., Jalsenjak I. - Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. - Int. J. Pharm., 135, 183-190, 1996.
92. Filipovic-Grcic J., Voinovich D., Moneghini M., Becirevic-Lacan M., Magarotto L., Jalsenjak I. - Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-β-cyclodextrin inclusion complex. - Eur. J. Pharm. Sci., 9, 373-379, 2000.
93. Cerchiara T., Luppi B., Bigucci F., Zecchi V. - Effect of chitosan on progesterone release from hydroxypropyl-β-cyclodextrin complexes. - Int. J. Pharm., 258, 209-215, 2003.
94. Zhang W.F., Chen X.G., Li P.W., He Q.Z., Zhou H.Y. - Chitosan and chitosan/beta-cyclodextrin microspheres as sustained-release drug carriers. - J. Appl. Polym. Sci., 103, 1183-1190, 2007.
95. Zhang W.F., Chen X.G., Li P.W., He Q.Z., Zhou H.Y., Cha D.S. - Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems. - J. Wuhan Univ.Technol., 23, 541-546, 2008.
96. Zhang W.F., Chen X.G., Li P.W., He Q.Z., Zhou H.Y. - Preparation and characterization of theophylline loaded chitosan/β-cyclodextrin microspheres. - J. Mater. Sci. Mater. Med., 19, 305-10, 2008.
97. Zhang W.F., Chen X.G., Li P.W., Liu C.S., He Q.Z. - Preparation and characterization of carboxymethyl chitosan and β-cyclodextrin microspheres by spray drying. - Dry Technol., 26, 108-115, 2008.
98. Bibby D.C., Davies N.M., Tucker I.G. - Poly(acrylic acid) microspheres containing β-cyclodextrin: loading and in vitro release of two dyes. - Int. J. Pharm., 187, 243-250, 1999.
99. Bibby D.C., Davies N.M., Tucker I.G. - Investigations into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres. - Int. J. Pharm., 180, 161-168, 1999.
100. Bibby D.C., Davies N.M., Tucker I.G.- Preparation and characterization of β-cyclodextrin and poly(acrylic acid) microspheres. - J. Microencapsul., 15, 629-637, 1998.
101. Blanco-Fuente H., Anguiano-Igea S., Otero-Espinar F.J., Blanco-Méndez J. - Kinetics of anhydride formation in xerogels of poly(acrylic acid). - Biomaterials, 17, 8, 1996.
102. Egawa Y., Shimura Y., Nowatari Y., Aiba D., Juni K. - Preparation of molecularly imprinted cyclodextrin microspheres. - Int. J. Pharm., 293, 165-170, 2005.
103. Pariot N., Edwards-Levy F., Andry M.C., Levy M.C. - Cross-linked beta-cyclodextrin microcapsules: preparation and properties. - Int. J. Pharm., 211, 19-27, 2000.
104. Pariot N., Edwards-Levy F., Andry M.C., Levy M.C. - Cross-linked beta-cyclodextrin microcapsules. II. Retarding effect on drug release through semi-permeable membranes. - Int. J. Pharm., 232, 175-181, 2002.
105. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. - Polysaccharides-based nanoparticles as drug delivery systems. - Adv. Drug Del. Rev., 60, 1650-1662, 2008.
106. Duchêne D., Wouessidjewe D., Ponchel G. - Cyclodextrins and carrier systems. - J. Control. Rel., 62, 263-268, 1999.
107. Roux M., Perly B., Djedaini-Pilard F. - Self-assemblies of amphiphilic cyclodextrins. - Eur. Biophys. J., 36, 861-867, 2007.
108. Skiba M., Duchêne D., Puisieux F., Wouessidjewe D. - Development of a new colloidal drug carrier from chemically-modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size. - Int. J. Pharm., 129, 113-121, 1996.
109. Lemos-Senna E., Wouessidjewe D., Lesieur S., Duchêne D. - Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. - Int. J. Pharm., 170, 119-128, 1998.
110. Gèze A., Aous S., Baussanne I., Putaux J.L., Defaye J., Wouessidjewe D. - Influence of chemical structure of amphiphilic β-cyclodextrins on their ability to form stable nanoparticles. - Int. J. Pharm., 242, 4, 2002.
111. Wouessidjewe D., Skiba M., Leroy-Lechat F., Lemos-Senna E., Puisieux F., Duchêne D. - A new concept in drug delivery based on "skirt-shaped cyclodextrin aggregates", Present state and future prospects. - STP Pharma Sci., 6, 21-28, 1996.
112. Memisoglu E., Bochot A., Sen M., Charon D., Duchêne D., Hincal A.A. - Amphiphilic β-cyclodextrins modified on the primary face: Synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules. - J. Pharm. Sci., 91, 1214-1224, 2002.
113. Memisoglu E., Bochot A., Ozalp M., Sen M., Duchêne D., Hincal A.A. - Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. - Pharm. Res., 20, 117-125, 2003.
114. Memisoglu-Bilensoy E., Sen M., Hincal A.A. - Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules. - J. Microencapsul., 23, 59-68, 2006.
115. Bilensoy E., Hincal A.A. - Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. - Expert Opin. Drug Del., 6, 1161-1173, 2009.
116. Memisoglu-Bilensoy E., Vural L., Bochot A., Renoir J.M., Duchêne D., Hincal A.A. - Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. - J. Control. Rel., 104, 489-496, 2005.
117. Bilensoy E., Gurkaynak O., Ertan M., Sen M., Hincal A.A. - Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel. - J. Pharm. Sci., 97, 1519-1529, 2008.
118. Bilensoy E., Gurkaynak O., Dogan A.L., Hincal A.A. - Safety and efficacy of amphiphilic β-cyclodextrin nanoparticles for paclitaxel delivery. - Int. J. Pharm., 347, 163-170, 2008.
119. da Silveira A.M., Duchêne D., Ponchel G. - Influence of solubility and partition coefficient on the loading of combined poly(isobutylcyanoacrylate) and hydroxypropyl-β-cyclodextrin nanoparticles by steroids. - STP Pharma Sci., 10, 309-314, 2000. (Pubitemid 30650490)
120. Sajeesh S., Sharma C.P. - Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. - Int. J. Pharm., 325, 147-154, 2006.
121. Liu Y.Y., Yu Y., Zhang G.B., Tang M.F. - Preparation, characterization, and controlled release of novel nanoparticles based on MMA/β-CD copolymers. - Macromol. Biosci., 7, 1250-1257, 2007.
122. Chiellini F., Bartoli C., Dinucci D., Piras A.M., Anderson R., Croucher T. - Bioeliminable polymeric nanoparticles for proteic drug delivery. - Int. J. Pharm., 343, 90-97, 2007.
123. Lopedota A., Trapani A., Cutrignelli A., Chiarantini L., Pantucci E., Curci R., Manuali E., Trapani G. - The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. - Eur. J. Pharm. Biopharm., 72, 509-520, 2009.
124. Park I.-K., von Recum H.A., Jiang S., Pun S.H. - Supramolecular assembly of cyclodextrin-based nanoparticles on solid surfaces for gene delivery. - Langmuir, 22, 8478-8484, 2006. (Pubitemid 44547074)
125. Cavalli R., Peira E., Caputo O., Gasco M.R. - Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins. - Int. J. Pharm., 182, 59-69, 1999.
126. Chirio D., Gallarate M., Trotta M., Carlotti M.E., Gaudino E.C., Cravotto G. - Influence of α- and γ-cyclodextrin lipophilic derivatives on curcumin-loaded SLN. - J. Incl. Phenom. Macro., 65, 391-402, 2009.
127. Chen Y., Siddalingappa B., Chan P.H.H., Benson H.A.E. - Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin. - Biopolymers, 90, 663-670, 2008.
128. Maestrelli F., Garcia-Fuentes M., Mura P., Alonso M.J. - A new drug nanocarrier consisting of chitosan and hydroxypropylcyclodextrin. - Eur. J. Pharm. Biopharm., 63, 79-86, 2006.
129. Ieva E., Trapani A., Cioffi N., Ditaranto N., Monopoli A., Sabbatini L. - Analytical characterization of chitosan nanoparticles for peptide drug delivery applications. - Anal. Bioanal. Chem., 393, 207-215, 2009.
130. Akiyoshi K., Sasaki Y., Sunamoto J. - Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B. - Bioconjugate Chem., 10, 321-324, 1999.
131. Akiyoshi K., Ueminami A., Kurumada S., Nomura Y. - Self-association of cholesteryl-bearing poly(L-lysine) in water and control of its secondary structure by host-guest interaction with cyclodextrin. - Macromolecules, 33, 6752-6756, 2000.
132. Daoud-Mahammed S., Ringard-Lefebvre C., Razzouq N., Rosilio V., Gillet B., Couvreur P., Amiel C., Gref R. - Spontaneous association of hydrophobized dextran and poly-β-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug. - J. Colloid Interf. Sci., 307, 83-93, 2007.
133. Daoud-Mahammed S., Grossiord J.L., Bergua T., Amiel C., Couvreur P., Gref R. - Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs. - J. Biomed. Mater. Res. A, 86A, 736-748, 2008.
134. Vyas A., Saraf S. - Cyclodextrin based novel drug delivery systems. - J. Incl. Phenom. Macro., 62, 23-42, 2008.
135. McCormack B., Gregoriadis G. - Drugs-in-cyclodextrins-in-liposomes, a novel concept in drug delivery. - Int. J. Pharm., 112, 249-258, 1994.
136. McCormack B., Gregoriadis G. - Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-β-cyclodextrin/drug complexes after intravenous injection into rats: Implications in drug delivery. - BBA-Gen. Subjects, 1291, 237-244, 1996.
137. McCormack B., Gregoriadis G. - Drugs-in-cyclodextrins-in-liposomes: an approach to controlling the fate of water insoluble drugs in vivo. - Int. J. Pharm., 162, 59-69, 1998.
138. Skalko N., Brandl M., Becirevic-Lacan M., Filipovic-Grcic J., Jalsenjak I. - Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison. - Eur. J. Pharm. Sci., 4, 359-366, 1996.
139. Loukas Y.L., Vraka V., Gregoriadis G. - Drugs, in cyclodextrins, in liposomes: a novel approach to the chemical stability of drugs sensitive to hydrolysis. - Int. J. Pharm., 162, 137-142, 1998.
140. Chakraborty K.K., Naik S.R. - In situ liposomal preparation containing amphotericin B: related toxicity and tissue disposition studies. - Pharm. Dev. Technol., 5, 543-553, 2000.
141. Chakraborty K.K., Naik S.R. - Pharmacokinetic studies of in situ liposomal preparation containing amphotericin B complexed with different chemically modified β-cyclodextrins. - J. Liposome Res., 11, 1-14, 2001.
142. Chakraborty K.K., Naik S.R. - Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin-beta complexed with different chemically modified β-cyclodextrins. - J. Pharm. Sci., 6, 231-237, 2003.
143. Skalko-Basnet N., Pavelic Z., Becirevic-Lacan M. - Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. - Drug Dev. Ind. Pharm., 26, 1279-1284, 2000.
144. Piette, M., Castagne, D., Delattre, L., and Piel, G. - Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. - J Incl Phenom Macro, 57, 101-103, 2007.
145. Maestrelli F., Gonzalez-Rodriguez M.L., Rabasco A.M., Mura P. - Preparation and characterisation of liposomes encapsulating ketoprofen- cyclodextrin complexes for transdermal drug delivery. - Int. J. Pharm., 298, 55-67, 2005.
146. Maestrelli F., Gonzalez-Rodriguez M.L., Rabasco A.M., Mura P. - Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. - Int. J. Pharm., 312, 53-60, 2006.
147. Nagarsenker M., Amin L., Date A. - Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation. - AAPS PharmSciTech, 9, 1165-1170, 2008.
148. Chirio D., Cavalli R., Trotta F., Carlotti M.E., Trotta M. - Deformable liposomes containing alkylcarbonates of β-cyclodextrins for dermal applications. - J. Incl. Phenom. Macro., 57, 645-649, 2007.
149. Arima H., Hagiwara Y., Hirayama F., Uekama K. - Enhancement of antitumor effect of doxorubicin by its complexation with β-cyclodextrin in pegylated liposomes. - J. Drug Target, 14, 225-232, 2006.
150. Hagiwara Y., Arima H., Hirayama F., Uekama K. - Prolonged retention of doxorubicin in tumor cells by encapsulation of β-cyclodextrin complex in pegylated liposomes. - J. Incl. Phenom. Macro., 56, 65-68, 2006.
151. Hagiwara Y., Arima H., Miyamoto Y., Hirayama F., Uekama K. - Preparation and pharmaceutical evaluation of liposomes entrapping salicylic acid/β-cyclodextrin conjugate. - Chem. Pharm. Bull., 54, 26-32, 2006.
152. Alvarez Lorenzo C., Rosa dos Santos J.F., Sosnik A., Torres Labandeira J.J., Concheiro A. - Hydrogels with cyclodextrins as highly versatile drug delivery systems. - In: Hanbook of Hydrogels: Properties, Preparation & Applications, D.B. Stein Ed., Nova Science Publishers, New York, 2009, pp. 1-42.
153. Babu R.J., Dayal P., Singh M. - Effect of cyclodextrins on the complexation and nasal permeation of melatonin. - Drug Deliv., 15, 381-388, 2008.
154. Garcia-Gonzalez N., Kellaway I.W., Blanco-Fuente H., Anguiano-Igea S., Delgado-Charro B., Otero-Espinar F.J., Blanco-Mendez J. - Influence of β-cyclodextrin concentration and polyacrylic acid molecular weight on swelling and release characteristics of metoclopramide-containing hydrogels. - Int. J. Pharm., 100, 25-31, 1993.
155. Blanco-Fuente H., Esteban-Fernandez B., Blanco-Mendez J., Otero-Espinar F.J. - Use of β-cyclodextrins to prevent modifications of the properties of Carbopol hydrogels due to Carbopol-drug interactions. - Chem. Pharm. Bull., 50, 40-46, 2002.
156. Tonelli A.E. - Nanostructuring and functionalizing polymers with cyclodextrins. - Polymer, 49, 1725-1736, 2008.
157. Zheng P.J., Hu X., Zhao X.Y., Li L., Tam K.C., Gan L.H. - Photoregulated sol-gel transition of novel azobenzene-functionalized hydroxypropyl methylcellulose and its β-cyclodextrin complexes. - Macromol. Rapid. Comm., 25, 678-682, 2004.
158. Alvarez-Lorenzo C., Deshmukh S., Bromberg L., Hatton T.A., Sandez-Macho I., Concheiro A. - Temperature- and light-responsive blends of pluronic F127 and poly(N,N-dimethylacrylamide-co-methacryloyloxyazobenzene). - Langmuir, 23, 11475-11481, 2007.
159. Fujita H., Ooya T., Yui N. - Thermally induced localization of cyclodextrins in a poly rotaxane consisting of β-cyclodextrins and poly(ethylene glycol)-poly(propylene glycol) triblock copolymer. - Macromolecules, 32, 7, 1999.
160. Nogueiras-Nieto L., Alvarez-Lorenzo C., Sandez-Macho I., Concheiro A., Otero-Espinar F.J. - Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state. - J. Phys. Chem. B, 113, 2773-2782, 2009.
161. Li J., Li X., Zhou Z., Ni X., Leong K.W. - Formation of supramolecular hydrogels induced by inclusion complexation between pluronics and β-cyclodextrin. - Macromolecules, 34, 7236-7237, 2001.
162. Rodriguez-Perez A.I., Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Concheiro A., Torres-Labandeira J.J. - Sertaconazole-HPβCD-Pluronic F127 solid inclusion complexes: characterization and effect on drug solubility. - J. Incl. Phenom. Macro., 57, 497-501, 2007.
163. Rodriguez-Perez A.I., Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Concheiro A., Torres-Labandeira J.J. - Drug solubilization and delivery from cyclodextrin-pluronic aggregates. - J. Nanosci. Nanotechnol., 6, 3179-3186, 2006.
164. Ooya T., Yui N. - Polyrotaxanes: synthesis, structure, and potential in drug delivery. - Crit. Rev. Ther. Drug, 16, 289-330, 1999.
165. Wenz G., Weickenmeier M., Huff J. - Association thickener by host-guest interaction of β-cyclodextrin polymers and guest polymers. - ACS Symposium Series, 765, 12, 2000.
166. Auzely-Velty R., Rinaudo M. - New supramolecular assemblies of a cyclodextrin-grafted chitosan through specific complexation. - Macromolecules, 35, 7955-7962, 2002.
167. Hashidzume A., Ito F., Tomatsu I., Harada A. - Macromolecular recognition by polymer-carrying cyclodextrins: Interaction of a polymer bearing cyclodextrin moieties with poly (acrylamide)s bearing aromatic side chains. - Macromol. Rapid. Comm., 26, 1151-1154, 2005.
168. Wintgens V., Charles M., Allouache F., Amiel C. - Triggering the thermosensitive properties of hydrophobically modified poly(N- isopropylacrylamide) by complexation with cyclodextrin polymers. - Macromol. Chem. Phys., 206, 1853-1861, 2005.
169. Wintgens V., Daoud-Mahammed S., Gref R., Bouteiller L., Amiel C. - Aqueous polysaccharide associations mediated by β-cyclodextrin polymers. - Biomacromolecules, 9, 1434-1442, 2008.
170. Gref R., Amiel C., Molinard K., Daoud-Mahammed S., Sebille B., Gillet B., Beloeil J.C., Ringard C., Rosilio V., Poupaert J., Couvreur P. - New self-assembled nanogels based on host-guest interactions: characterization and drug loading. - J. Control. Rel., 111, 316-324, 2006.
171. Gosselet N.M., Wintgens V., Amiel C. - Associative pH sensitive system. - Macromol. Biosci., 5, 306-313, 2005.
172. Crini G. - Recent developments in polysaccharide-based materials used as adsorbents in wastewater treatment. - Prog. Polym. Sci., 30, 38-70, 2005.
173. Sevillano X., Isasi J.R., Penas F.J. - Feasibility study of degradation of phenol in a fluidized bed bioreactor with a cyclodextrin polymer as biofilm carrier. - Biodegradation, 19, 589-597, 2008.
174. Wang H.D., Chu L.Y., Song H., Yang J.P., Xie R., Yang M. - Preparation and enantiomer separation characteristics of chitosan/beta-cyclodextrin composite membranes. - J. Membrane Sci., 297, 262-270, 2007.
175. Schneiderman E., Stalcup A.M. - Cyclodextrins: a versatile tool in separation science. - J. Chromatogr. B, 745, 83-102, 2000.
176. Scriba G.K.E. - Cyclodextrins in capillary electrophoresis enantioseparations, Recent developments and applications. - J. Sep. Sci., 31, 1991-2011, 2008.
177. Zhang J.T., Huang S.W., Gao F.Z., Zhuo R.X. - Novel temperature- sensitive, β-cyclodextrin-incorporated poly(N-isopropylacrylamide) hydrogels for slow release of drug. - Colloid Polym. Sci., 283, 461-464, 2005.
178. Zhang J.T., Xue Y.N., Gao F.Z., Huang S.W., Zhuo R.X. - Preparation of temperature-sensitive poly(N-isopropylacrylamide)/β-cyclodextrin-grafted polyethylenimine hydrogels for drug delivery. - J. Appl. Polym. Sci., 108, 3031-3037, 2008.
179. Liu Y.Y., Fan X.D., Kang T., Sun L. - A cyclodextrin microgel for controlled release driven by inclusion effects. - Macromol. Rapid. Comm., 25, 1912-1916, 2004.
180. Tsai H.A., Syu M.J. - Synthesis of creatinine-imprinted poly(β-cyclodextrin) for the specific binding of creatinine. - Biomaterials, 26, 2759-2766, 2005.
181. Komiyama M., Hirai H. - Preparation of immobilized β-cyclodextrins by use of alkanediol diglycidyl ethers as cross-linking agents and their guest binding abilities. - Polym. J., 19, 773-775, 1987.
182. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., Torres-Labandeira J.J. - New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. - Pharm. Res., 23, 121-130, 2006.
183. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., Torres-Labandeira J.J. - Estradiol sustained release from high affinity cyclodextrin hydrogels. - Eur. J. Pharm. Biopharm., 66, 55-62, 2007.
184. Lopez-Montero E., Rosa dos Santos J.F., Torres-Labandeira J.J., Concheiro A., Alvarez-Lorenzo C. - Sertaconazole-loaded cyclodextrin-polysaccharide hydrogels for improved antifungal activity. - Open Drug Del. J., 3, 1-9, 2009,.
185. Rodriguez-Tenreiro C., Diez-Bueno L., Concheiro A., Torres-Labandeira J.J., Alvarez-Lorenzo C. - Cyclodextrin/carbopol micro-scale interpenetrating networks (ms-IPNs) for drug delivery. - J. Control. Rel., 123, 56-66, 2007.
186. Lee C.K., Kim E.J., Jun J.H. - Determination of relative reactivities of free hydroxyl groups in β-cyclodextrin, amylose, and cellulose by reductive-cleavage method. - Bull. Korean Chem. Soc., 20, 5, 1999.
187. Lee M.H., Yoon K.J., Ko S. -W. - Synthesis of a vinyl monomer containing β-cyclodextrin and grafting onto cotton fiber. - J. Appl. Polym. Sci., 80, 438-446, 2001.
188. Zhang J.T., Huang S.W., Zhuo R.X. - Preparation and characterization of novel temperature sensitive poly (N-isopropylacrylamide-co-acryloyl β-cyclodextrin) hydrogels with fast shrinking kinetics. - Macromol. Chem. Phys., 205, 107-113, 2004.
189. Asanuma H., Akiyama T., Kajiya K., Hishiya T., Komiyama M. - Molecular imprinting of cyclodextrin in water for the recognition of nanometer-scaled guests. - Anal. Chim. Acta, 435, 25-33, 2001.
190. Piletsky S.A., Andersson H.S., Nicholls I.A. - Combined hydrophobic and electrostatic interaction-based recognition in molecularly imprinted polymers. - Macromolecules, 32, 633-636, 1999.
191. Piletsky S.A., Andersson K.S., Nicholls I.A. - On the role of electrostatic interactions in the enantioselective recognition of phenylalanine in molecularly imprinted polymers incorporating β-cyclodextrin. - Polym. J., 37, 793-796, 2005.
192. Liu Y.Y., Fan X.D. - Synthesis and characterization of pH- and temperature-sensitive hydrogel of N-isopropylacrylamide/cyclodextrin based copolymer. - Polymer, 43, 4997-5003, 2002.
193. Zawko S.A., Truong Q., Schmidt C.E. - Drug-binding hydrogels of hyaluronic acid functionalized with β-cyclodextrin. - J. Biomed. Mater. Res. A, 87A, 1044-1052, 2008.
194. Shan T., Chen J., Yang L.M., Jie S.W., Qian G. - Radiation preparation and characterization of pH-sensitive hydrogel of acrylic acid/cyclodextrin based copolymer. - J. Radioanal. Nucl. Ch., 279, 75-82, 2009.
195. Liu Y.Y., Fan X.D., Hu H., Tang Z.H. - Release of chlorambucil from poly(N-isopropylacrylamide) hydrogels with β-cyclodextrin moieties. - Macromol. Biosci., 4, 729-736, 2004.
196. Wang Q., Li S., Wang Z., Liu H., Li C. - Preparation and characterization of a positive thermoresponsive hydrogel for drug loading and release. - J. Appl. Polym. Sci., 111, 1417-1425, 2009.
197. Ma D., Zhang L.M., Yang C., Yan L. - UV photopolymerized hydrogels with β-cyclodextrin moieties. - J. Polym. Res., 15, 301-307, 2008.
198. Lu D.D., Yang L.Q., Zhou T.H., Lei Z.Q. - Synthesis, characterization and properties of biodegradable polylactic acid-β-cyclodextrin cross-linked copolymer microgels. - Eur. Polym. J., 44, 2140-2145, 2008.
199. Rosas dos Santos J.F., Couceiro R., Concheiro A., Torres-Labandeira J.J., Alvarez-Lorenzo C. - Poly(hydroxyethyl methacrylate-co-methacrylated-ß- cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. - Acta Biomater., 4, 745-755, 2008.
200. Zhao X., Courtney J.M. - Surface modification of polymeric biomaterials: utilization of cyclodextrins for blood compatibility improvement. - J. Biomed. Mater. Res. A, 80A, 539-553, 2007.
201. Blanchemain N., Chai F., Haulon S., Krump-Konvalinkova V., Traisnel M., Morcellet M., Martel B., Kirkpatrick C.J., Hildebrand H.F. - Biological behaviour of an endothelial cell line (HPMEC) on vascular prostheses grafted with hydroxypropyl-γ-cyclodextrin (HPγCD) and hydroxypropyl-β- cyclodextrin (HPβCD). - J. Mater. Sci.-Mater. M, 19, 2515-2523, 2008.
202. Rosa dos Santos J.F., Alvarez-Lorenzo C., Silva M., Balsa L., Couceiro J., Torres-Labandeira J.J., Concheiro A. - Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. - Biomaterials, 30, 1348-1355, 2009.
203. Shangraw R.F., Pande G.S., Gala P. - Characterization of the tableting properties of β-cyclodextrin and the effects of processing variables on inclusion complex formation, compactibility and dissolution. - Drug Dev. Ind. Pharm., 18, 1831-1851, 1992.
204. Sotthivirat S., Haslam J.L., Stella V.J. - Evaluation of various properties of alternative salt forms of sulfobutylether-β-cyclodextrin, (SBE)(7M)-β-CD. - Int. J. Pharm., 330, 73-81, 2007.